Jim O'Neill was nominated to advise HHS on operations and questioned regarding drug pricing deals after succeeding as deputy secretary.
1 report, 1 independent
Updated Sep 16
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Jim O'Neill was nominated to advise HHS on operations and questioned regarding drug pricing deals after succeeding as deputy secretary.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Department of Health & Human Services
government department in the state of Victoria, Australia
-
Elizabeth Warren
American politician (born 1949)
Related events
- Trump administration mandates new HHS rules, which are subsequently challenged by Keith Ellison's office.
- The Administration negotiated confidential deals on drug prices using HHS officials, involving major pharmaceutical companies.
- Robert F. Kennedy Jr. served as health secretary for HHS and was involved in FDA leadership decisions.
- Trump signed an executive order accelerating agriculture modernization and directed HHS and EPA to focus on food safety and chemical exposures.